@RahulBanerjeeMD @vekennedy @SandyWong02111 Totally agreed. There are already published diagnostic criteria for CAR-T-associated HLH/MAS by Neelapu et al. 2018 (https://t.co/U5tE4iTAii), but the major issue is a dearth of literature on how to manage it …
3349万3407円で話題のキムリア。脳症「CAR‑T‑cell‑related encephalopathy syndrome (CRES)」がsecond most‑common adverse eventとのこと。Management → https://t.co/NTuB0sd0f6
RT @Raul10_Faronc: Excelente revisión sobre manejo de toxicidad de CART cells. 2018 pero aún es actual. "Chimeric antigen receptor T-cell…
RT @Raul10_Faronc: Excelente revisión sobre manejo de toxicidad de CART cells. 2018 pero aún es actual. "Chimeric antigen receptor T-cell…